Irritable Bowel Syndrome Treatment Market 2027 By Type, Product and Geography | The Insight Partners

Irritable Bowel Syndrome Treatment Market to 2027 - Global Analysis and Forecasts By Type (IBS-C, IBS-D) ; Product (Xifaxan, Linzess/Constella, Viberzi, Amitiza) , and Geography

Report Code: TIPRE00006814 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Irritable bowel syndrome (IBS) is the disorder that attacks the large intestine. Cramping, abdominal pain, bloating, gas, and diarrhea or constipation are the signs and symptoms of this common disorder. This disorder or symptoms can be controlled by symptoms by managing diet, lifestyle, and stress. However, those who can't need medication and counseling.

MARKET DYNAMICS

Irritable Bowel Syndrome Treatment market is anticipated to grow in the forecast period owing to rising prevalence of target disease, coupled with increasing uptake of drugs for the same, and FDA approvals for new prescription drugs. Moreover, rising commercialization of existing products in different regions is also offering opportunities in the market growth during the forecast period.

MARKET SCOPE

The "Global Irritable Bowel Syndrome Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Irritable Bowel Syndrome Treatment market with detailed market segmentation by type, product and geography. The global Irritable Bowel Syndrome Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Irritable Bowel Syndrome Treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Irritable Bowel Syndrome Treatment market is segmented on the basis of type, and product. Based on type, the market is segmented as IBS?C, and IBS?D. Based on product, the market is segmented as Xifaxan, Linzess/Constella, Viberzi, and Amitiza.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Irritable Bowel Syndrome Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Irritable Bowel Syndrome Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Irritable Bowel Syndrome Treatment market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Irritable Bowel Syndrome Treatment market in these regions.

MARKET PLAYERS


The report covers key developments in the Irritable Bowel Syndrome Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Irritable Bowel Syndrome Treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Irritable Bowel Syndrome Treatment in the global market. Below mentioned is the list of few companies engaged in the Irritable Bowel Syndrome Treatment market.

The report also includes the profiles of key Irritable Bowel Syndrome Treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  IRONWOOD PHARMACEUTICALS, INC.
  •  ALLERGAN
  •  ASTELLAS PHARMA, INC.
  •  TAKEDA PHARMACEUTICAL COMPANY LIMITED
  •  ASTRAZENECA
  •  SEBELA PHARMACEUTICALS INC.
  •  SYNERGY PHARMACEUTICALS INC.
  •  SYNTHETIC BIOLOGICS, INC.
  •  BAUSCH HEALTH
  •  ARDELYX
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Irritable Bowel Syndrome Treatment Market - By Type
1.3.2 Irritable Bowel Syndrome Treatment Market - By Product
1.3.3 Irritable Bowel Syndrome Treatment Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. IRRITABLE BOWEL SYNDROME TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. IRRITABLE BOWEL SYNDROME TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. IRRITABLE BOWEL SYNDROME TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. IRRITABLE BOWEL SYNDROME TREATMENT - GLOBAL MARKET OVERVIEW
6.2. IRRITABLE BOWEL SYNDROME TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. IRRITABLE BOWEL SYNDROME TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. IBS-C
7.3.1. Overview
7.3.2. IBS-C Market Forecast and Analysis
7.4. IBS-D
7.4.1. Overview
7.4.2. IBS-D Market Forecast and Analysis

8. IRRITABLE BOWEL SYNDROME TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. XIFAXAN
8.3.1. Overview
8.3.2. Xifaxan Market Forecast and Analysis
8.4. LINZESS/CONSTELLA
8.4.1. Overview
8.4.2. Linzess/Constella Market Forecast and Analysis
8.5. VIBERZI
8.5.1. Overview
8.5.2. Viberzi Market Forecast and Analysis
8.6. AMITIZA
8.6.1. Overview
8.6.2. Amitiza Market Forecast and Analysis

9. IRRITABLE BOWEL SYNDROME TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Irritable Bowel Syndrome Treatment Market Overview
9.1.2 North America Irritable Bowel Syndrome Treatment Market Forecasts and Analysis
9.1.3 North America Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Type
9.1.4 North America Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Product
9.1.5 North America Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Irritable Bowel Syndrome Treatment Market
9.1.5.1.1 United States Irritable Bowel Syndrome Treatment Market by Type
9.1.5.1.2 United States Irritable Bowel Syndrome Treatment Market by Product
9.1.5.2 Canada Irritable Bowel Syndrome Treatment Market
9.1.5.2.1 Canada Irritable Bowel Syndrome Treatment Market by Type
9.1.5.2.2 Canada Irritable Bowel Syndrome Treatment Market by Product
9.1.5.3 Mexico Irritable Bowel Syndrome Treatment Market
9.1.5.3.1 Mexico Irritable Bowel Syndrome Treatment Market by Type
9.1.5.3.2 Mexico Irritable Bowel Syndrome Treatment Market by Product
9.2. EUROPE
9.2.1 Europe Irritable Bowel Syndrome Treatment Market Overview
9.2.2 Europe Irritable Bowel Syndrome Treatment Market Forecasts and Analysis
9.2.3 Europe Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Type
9.2.4 Europe Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Product
9.2.5 Europe Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Irritable Bowel Syndrome Treatment Market
9.2.5.1.1 Germany Irritable Bowel Syndrome Treatment Market by Type
9.2.5.1.2 Germany Irritable Bowel Syndrome Treatment Market by Product
9.2.5.2 France Irritable Bowel Syndrome Treatment Market
9.2.5.2.1 France Irritable Bowel Syndrome Treatment Market by Type
9.2.5.2.2 France Irritable Bowel Syndrome Treatment Market by Product
9.2.5.3 Italy Irritable Bowel Syndrome Treatment Market
9.2.5.3.1 Italy Irritable Bowel Syndrome Treatment Market by Type
9.2.5.3.2 Italy Irritable Bowel Syndrome Treatment Market by Product
9.2.5.4 Spain Irritable Bowel Syndrome Treatment Market
9.2.5.4.1 Spain Irritable Bowel Syndrome Treatment Market by Type
9.2.5.4.2 Spain Irritable Bowel Syndrome Treatment Market by Product
9.2.5.5 United Kingdom Irritable Bowel Syndrome Treatment Market
9.2.5.5.1 United Kingdom Irritable Bowel Syndrome Treatment Market by Type
9.2.5.5.2 United Kingdom Irritable Bowel Syndrome Treatment Market by Product
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Irritable Bowel Syndrome Treatment Market Overview
9.3.2 Asia-Pacific Irritable Bowel Syndrome Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Product
9.3.5 Asia-Pacific Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 China Irritable Bowel Syndrome Treatment Market
9.3.5.1.1 China Irritable Bowel Syndrome Treatment Market by Type
9.3.5.1.2 China Irritable Bowel Syndrome Treatment Market by Product
9.3.5.2 India Irritable Bowel Syndrome Treatment Market
9.3.5.2.1 India Irritable Bowel Syndrome Treatment Market by Type
9.3.5.2.2 India Irritable Bowel Syndrome Treatment Market by Product
9.3.5.3 Japan Irritable Bowel Syndrome Treatment Market
9.3.5.3.1 Japan Irritable Bowel Syndrome Treatment Market by Type
9.3.5.3.2 Japan Irritable Bowel Syndrome Treatment Market by Product
9.3.5.4 South Korea Irritable Bowel Syndrome Treatment Market
9.3.5.4.1 South Korea Irritable Bowel Syndrome Treatment Market by Type
9.3.5.4.2 South Korea Irritable Bowel Syndrome Treatment Market by Product
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Irritable Bowel Syndrome Treatment Market Overview
9.4.2 Middle East and Africa Irritable Bowel Syndrome Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Product
9.4.5 Middle East and Africa Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Irritable Bowel Syndrome Treatment Market
9.4.5.1.1 South Africa Irritable Bowel Syndrome Treatment Market by Type
9.4.5.1.2 South Africa Irritable Bowel Syndrome Treatment Market by Product
9.4.5.2 Saudi Arabia Irritable Bowel Syndrome Treatment Market
9.4.5.2.1 Saudi Arabia Irritable Bowel Syndrome Treatment Market by Type
9.4.5.2.2 Saudi Arabia Irritable Bowel Syndrome Treatment Market by Product
9.4.5.3 U.A.E Irritable Bowel Syndrome Treatment Market
9.4.5.3.1 U.A.E Irritable Bowel Syndrome Treatment Market by Type
9.4.5.3.2 U.A.E Irritable Bowel Syndrome Treatment Market by Product
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Irritable Bowel Syndrome Treatment Market Overview
9.5.2 South and Central America Irritable Bowel Syndrome Treatment Market Forecasts and Analysis
9.5.3 South and Central America Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Type
9.5.4 South and Central America Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Product
9.5.5 South and Central America Irritable Bowel Syndrome Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Argentina Irritable Bowel Syndrome Treatment Market
9.5.5.1.1 Argentina Irritable Bowel Syndrome Treatment Market by Type
9.5.5.1.2 Argentina Irritable Bowel Syndrome Treatment Market by Product

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. IRRITABLE BOWEL SYNDROME TREATMENT MARKET, KEY COMPANY PROFILES
11.1. IRONWOOD PHARMACEUTICALS, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ALLERGAN
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ASTELLAS PHARMA, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ASTRAZENECA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SEBELA PHARMACEUTICALS INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SYNERGY PHARMACEUTICALS INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SYNTHETIC BIOLOGICS, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BAUSCH HEALTH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ARDELYX
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. IRONWOOD PHARMACEUTICALS, INC.
2. ALLERGAN
3. ASTELLAS PHARMA, INC.
4. TAKEDA PHARMACEUTICAL COMPANY LIMITED
5. ASTRAZENECA
6. SEBELA PHARMACEUTICALS INC.
7. SYNERGY PHARMACEUTICALS INC.
8. SYNTHETIC BIOLOGICS, INC.
9. BAUSCH HEALTH
10. ARDELYX